Skip to content

MedCaT

Active
Private limited companyfounded 200719 yrs activeLuxemburgstraat 20, 9140 Temse, BelgiumKBO/BCE: BE 0889.559.581
Summary

MedCaT has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €78,250 and a net result of €5,880. Equity is growing by ~9.8% per year across the filed fiscal years. Its solvency ranks better than 93% of 18626 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability54▲+4
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity ample (current ratio 8.97 against 15.33 in 2024; short-term debt: 11.1% and cash: 37.6% of total assets), and 11.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 19 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
88.9%
Return on assets
6.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 d early
2024
79 d early
2023
58 d early
2022
88 d early
2021
87 d early
2020
66 d early
2019
84 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 70 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 May (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 22 May 2007, MedCaT was incorporated.1 Total assets went from EUR 52,311 in 2018 to EUR 88,066 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Source amounts without an identifiable currency are assumed to be EUR.

Equity
€78,250▲ 8.1%
2024 · €72,370
Total assets
€88,066▲ 13.8%
2024 · €77,420
Net result
€5,880▲ 48.7%
2024 · €3,953
Working capital
€78,250▲ 8.1%
2024 · €72,370
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€9,908▼ 19.8%€9,665▼ 2.4%€5,154▼ 46.7%€5,711▲ 10.8%€7,312▲ 28.0%
Net result€7,091within the sector's middle half▼ 24.9%€6,960within the sector's middle half▼ 1.9%€2,953below the sector's middle half▼ 57.6%€3,953within the sector's middle half▲ 33.9%€5,880within the sector's middle half▲ 48.7%
Equity€58,504below the sector's middle half▲ 13.8%€65,464below the sector's middle half▲ 11.9%€68,417below the sector's middle half▲ 4.5%€72,370below the sector's middle half▲ 5.8%€78,250within the sector's middle half▲ 8.1%
Total assets€71,596below the sector's middle half▲ 24.5%€70,464below the sector's middle half▼ 1.6%€71,734below the sector's middle half▲ 1.8%€77,420below the sector's middle half▲ 7.9%€88,066within the sector's middle half▲ 13.8%
Debt€13,092▲ 114%€5,000▼ 61.8%€3,317▼ 33.7%€5,050▲ 52.2%€9,816▲ 94.4%
Working capital€58,516within the sector's middle half▲ 13.8%€65,476within the sector's middle half▲ 11.9%€68,429within the sector's middle half▲ 4.5%€72,370within the sector's middle half▲ 5.8%€78,250within the sector's middle half▲ 8.1%
Solvency81.7%above the sector's middle half▼ 7.7pp92.9%above the sector's middle half▲ 11.2pp95.4%above the sector's middle half▲ 2.5pp93.5%above the sector's middle half▼ 1.9pp88.9%above the sector's middle half▼ 4.6pp
Current ratio5.47above the sector's middle half▼ 3.9414.13above the sector's middle half▲ 8.6521.70above the sector's middle half▲ 7.5815.33above the sector's middle half▼ 6.378.97above the sector's middle half▼ 6.36
Return on assets (ROA)9.9%within the sector's middle half▼ 6.5pp9.9%within the sector's middle half=4.1%within the sector's middle half▼ 5.8pp5.1%within the sector's middle half▲ 1.0pp6.7%within the sector's middle half▲ 1.6pp
Staff (FTE)
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€2,500€5,000€7,500€10,000Operating result 2021: €9,908€9,908Net result 2021: €7,091€7,091Operating result 2022: €9,665€9,665Net result 2022: €6,960€6,960Operating result 2023: €5,154€5,154Net result 2023: €2,953€2,953Operating result 2024: €5,711€5,711Net result 2024: €3,953€3,953Operating result 2025: €7,312€7,312Net result 2025: €5,880€5,88020212022202320242025€0€2,000€4,000€6,000€8,000Operating result 2023: €5,154€5,150Net result 2023: €2,953€2,950Operating result 2024: €5,711€5,710Net result 2024: €3,953€3,950Operating result 2025: €7,312€7,310Net result 2025: €5,880€5,880202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 28% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €88,066
Equity €78,250 ▲ 8.1%
Debt €9,816 ▲ 94.4%
Debt's share of the balance-sheet total rises from 6.5% to 11.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
Debt to equity
0.13▲
2024 · 0.07
ROE
7.5%▲
2024 · 5.5%
Debt ≤ 1 year
€9,816▲
2024 · €5,050
Income taxes
€2,018▲
2024 · €1,318
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,696 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.9% stopped otherwise
95% still going

For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,696 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 36 lines
Balance sheet Code20242025
Assets
Total assets20/58€77,420€88,066▲
Current assets29/58€77,420€88,066▲
Stocks and contracts in progress3€0-
Stocks30/36€0-
Amounts receivable within one year40/41€8,692€54,792▲
Trade receivables40€7,329€10,199▲
Other amounts receivable41€1,364€44,593▲
Cash at bank and in hand54/58€68,469€33,116▼
Deferred charges and accrued income490/1€258€158▼
Equity and liabilities
Total equity and liabilities10/49€77,420€88,066▲
Equity10/15€72,370€78,250▲
Contributions10/11€18,600€18,600=
Reserves13€53,770€59,650▲
Distributable reserves133€53,770€59,650▲
Amounts payable17/49€5,050€9,816▲
Amounts payable within one year42/48€5,050€9,816▲
Trade debts44€729€8,798▲
Suppliers440/4€729€8,798▲
Taxes, remuneration and social security45-€1,018
Taxes450/3-€1,018
Other amounts payable47/48€4,320€0▼
Accrued charges and deferred income492/3€0-
Income statement Code20242025
Other operating charges640/8€528€403▼
Gross operating margin9900€6,238€7,715▲
Operating profit (loss)9901€5,711€7,312▲
Financial income75/76B€23€920▲
Recurring financial income75€23€920▲
Financial charges65/66B€462€334▼
Recurring financial charges65€462€334▼
Profit (loss) for the period before taxes9903€5,271€7,898▲
Income taxes67/77€1,318€2,018▲
Profit (loss) for the period9904€3,953€5,880▲
Profit (loss) for the period to be appropriated9905€3,953€5,880▲
Appropriation of the result
Profit (loss) to be appropriated9906€3,953€5,880▲
Transfer to equity691/2€3,953€5,880▲
To other reserves6921€3,953€5,880▲

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Other operating charges640/8€449€450€625€528€403▼ 23.6%
Gross operating margin9900€10,356€10,115€5,779€6,238€7,715▲ 23.7%
Operating profit (loss)9901€9,908€9,665€5,154€5,711€7,312▲ 28.0%
Financial income75/76B€333€0-€23€920▲ 3,979%
Recurring financial income75€333€0-€23€920▲ 3,979%
Financial charges65/66B€786€396€1,217€462€334▼ 27.7%
Recurring financial charges65€786€396€1,217€462€334▼ 27.7%
Profit (loss) for the period before taxes9903€9,455€9,270€3,937€5,271€7,898▲ 49.8%
Income taxes67/77€2,364€2,310€984€1,318€2,018▲ 53.1%
Profit (loss) for the period9904€7,091€6,960€2,953€3,953€5,880▲ 48.7%
Profit (loss) for the period to be appropriated9905€7,091€6,960€2,953€3,953€5,880▲ 48.7%
Line20212022202320242025Change
Assets
Total assets20/58€71,596€70,464€71,734€77,420€88,066▲ 13.8%
Current assets29/58€71,596€70,464€71,734€77,420€88,066▲ 13.8%
Stocks and contracts in progress3€3,383€3,794€4,345€0--
Stocks30/36€3,383€3,794€4,345€0--
Amounts receivable within one year40/41€15,062€6,574€10,565€8,692€54,792▲ 530%
Trade receivables40€13,775€5,266€8,026€7,329€10,199▲ 39.2%
Other amounts receivable41€1,287€1,308€2,539€1,364€44,593▲ 3,170%
Cash at bank and in hand54/58€53,151€59,874€56,682€68,469€33,116▼ 51.6%
Deferred charges and accrued income490/1-€222€142€258€158▼ 38.8%
Equity and liabilities
Total equity and liabilities10/49€71,596€70,464€71,734€77,420€88,066▲ 13.8%
Equity10/15€58,504€65,464€68,417€72,370€78,250▲ 8.1%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€39,904€46,864€49,817€53,770€59,650▲ 10.9%
Non-distributable reserves130/1€1,860€1,860€0---
Reserves not available under the articles1311€1,860€1,860€0---
Distributable reserves133€38,044€45,004€49,817€53,770€59,650▲ 10.9%
Amounts payable17/49€13,092€5,000€3,317€5,050€9,816▲ 94.4%
Amounts payable within one year42/48€13,080€4,988€3,305€5,050€9,816▲ 94.4%
Trade debts44€13,080€4,758€1,274€729€8,798▲ 1,106%
Suppliers440/4€13,080€4,758€1,274€729€8,798▲ 1,106%
Taxes, remuneration and social security45----€1,018-
Taxes450/3----€1,018-
Other amounts payable47/48-€230€2,031€4,320€0▼ 100%
Accrued charges and deferred income492/3€12€12€12€0--
Line20212022202320242025Change
Profit (loss) for the period9904€7,091€6,960€2,953€3,953€5,880▲ 48.7%
Operating cash flow (approximation)€7,091€6,960€2,953€3,953€5,880▲ 48.7%
Change in cash-€6,723-€3,192€11,788-€35,354▼ 400%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
13-05
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
03-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Weakest financial yearnet €2,953 ▼57.6%
Net result drops to €2,953, the lowest in the series; recovery starts the following year.
04-05
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Liquidity triplescurrent ratio 14.13
Current ratio from 5.47 to 14.13; short-term debt falls from €13,080 to €4,988.
05-05
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
26-05
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Highest result since 2018net €9,439 ▲5.2%
Net result €9,439, the highest in the series.
31-12
Financial Liquidity triplescurrent ratio 9.41
Current ratio from 3.17 to 9.41; short-term debt falls from €16,484 to €6,113.
08-05
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
20-05
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
07-05
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
08-05
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Temse · 1 establishment unit since 2007
seat establishment The establishment unit on the map
Ground area
7,219 m²
Building footprint
1,412 m²
Volume, LiDAR
16,298 m³
Parcel 46025B0179/09E000, Flanders · tallest building 16.4 m, ±4 floors. Linked by address, not a title deed.
309 companies at this address See who is registered here
1 establishment unit
MedCat
Luxemburgstraat 20, 9140 TemseNACE 5146002
since 20072.162.912.829
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
46025B0179/09E000 Flanders 7,219 m² 1 · 1,412 m² 16.4 m · 4 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,071 companies in sector 47741 we hold annual accounts for 645. 468 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded22-05-2007
Fiscal year end31-12
Activities, NACEBEL 2025
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
46460Wholesale of pharmaceutical and medical goods
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.